a Department of Pediatrics, University of South Florida, Tampa, Florida
b Universidad Austral, Valdivia, Chile
c Hospital Nuestra Senora de la Candelaria, Tenerife, Spain
d Hospital Las Palmas, Gran Canaria, Spain
e Department of Pediatrics, University of Florida, Gainesville, Florida
OBJECTIVES. To evaluate the role of primary vesicoureteral reflux (VUR) in increasing the frequency and severity of urinary tract infections (UTIs) and renal parenchymal damage among patients with acute pyelonephritis and to determine whether urinary antibiotic prophylaxis reduces the frequency and/or severity of UTIs and/or prevents renal parenchymal damage among patients with mild/moderate VUR.
METHODS. Patients 3 months to 18 years of age with acute pyelonephritis, with or without VUR, were assigned randomly to receive urinary antibiotic prophylaxis or not. Patients were monitored every 3 months for 1 year. Dimercaptosuccinic acid renal scans were repeated at 6 months or if there was a recurrence of febrile UTI. Urinalysis and urine culture were performed at each clinic visit. Renal ultrasound scans and voiding cystourethrograms were repeated at the end of 1 year of follow-up monitoring.
RESULTS. Of the 236 patients enrolled in the study, 218 completed the 1-year follow-up monitoring. Groups were similar with respect to age, gender, and reflux grade distribution for those with VUR. No statistically significant differences were found among the groups with respect to rate of recurrent UTI, type of recurrence, rate of subsequent pyelonephritis, and development of renal parenchymal scars.
CONCLUSIONS. After 1 year of follow-up monitoring, mild/moderate VUR does not increase the incidence of UTI, pyelonephritis, or renal scarring after acute pyelonephritis. Moreover, a role for urinary antibiotic prophylaxis in preventing the recurrence of infection and the development of renal scars is not supported by this study.
Key Words: vesicoureteral reflux urinary antibiotic prophylaxis acute pyelonephritis
Abbreviations: VURvesicoureteral reflux UTIurinary tract infection DMSAdimercaptosuccinic acid VCUGvoiding cystourethrogram
This article has been cited by other articles:
![]() |
M. Pennesi, L. Travan, L. Peratoner, A. Bordugo, A. Cattaneo, L. Ronfani, S. Minisini, A. Ventura, and for the North East Italy Prophylaxis in VUR study Is Antibiotic Prophylaxis in Children With Vesicoureteral Reflux Effective in Preventing Pyelonephritis and Renal Scars? A Randomized, Controlled Trial Pediatrics, June 1, 2008; 121(6): e1489 - e1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Palmer Antibiotic Prophylaxis for Vesicoureteral Reflux Revisited AAP Grand Rounds, May 1, 2008; 19(5): 49 - 50. [Full Text] [PDF] |
||||
![]() |
G. Williams, J. T. Fletcher, S. I. Alexander, and J. C. Craig Vesicoureteral Reflux J. Am. Soc. Nephrol., May 1, 2008; 19(5): 847 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bouissou, C. Munzer, S. Decramer, B. Roussel, R. Novo, D. Morin, M. P. Lavocat, C. Guyot, S. Taque, M. Fischbach, et al. Prospective, Randomized Trial Comparing Short and Long Intravenous Antibiotic Treatment of Acute Pyelonephritis in Children: Dimercaptosuccinic Acid Scintigraphic Evaluation at 9 Months Pediatrics, March 1, 2008; 121(3): e553 - e560. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Conway, A. Cnaan, T. Zaoutis, B. V. Henry, R. W. Grundmeier, and R. Keren Recurrent Urinary Tract Infections in Children: Risk Factors and Association With Prophylactic Antimicrobials JAMA, July 11, 2007; 298(2): 179 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Garin and L. Young Much Pain, Little Gain From Voiding Cystourethrogram After Urinary Tract Infection Pediatrics, July 1, 2007; 120(1): 249 - 250. [Full Text] [PDF] |
||||
![]() |
S. D Marks How have the past 5 years of research changed clinical practice in paediatric nephrology? Arch. Dis. Child., April 1, 2007; 92(4): 357 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Bundy and J. R. Serwint Vesicoureteral Reflux Pediatr. Rev., February 1, 2007; 28(2): e6 - e8. [Full Text] [PDF] |
||||
![]() |
N. M. Oreskovic and E. U. Sembrano Repeat Urine Cultures in Children Who Are Admitted With Urinary Tract Infections Pediatrics, February 1, 2007; 119(2): e325 - e329. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Newman Much Pain, Little Gain From Voiding Cystourethrograms After Urinary Tract Infection Pediatrics, November 1, 2006; 118(5): 2251 - 2251. [Full Text] [PDF] |
||||
![]() |
E. R. Wald Much Pain, Little Gain From Voiding Cystourethrograms After Urinary Tract Infection: In Reply Pediatrics, November 1, 2006; 118(5): 2251a - 2252. [Full Text] [PDF] |
||||
![]() |
R. Lehman Evidently... Evid. Based Med., October 1, 2006; 11(5): 136 - 136. [Full Text] [PDF] |
||||
![]() |
Other articles noted Evid. Based Med., October 1, 2006; 11(5): 159 - 160. [Full Text] [PDF] |
||||
![]() |
JOURNAL WATCH PEDIATRICS & ADOLESCENT MEDICINE Arch. Dis. Child., August 1, 2006; 91(8): 712 - 713. [Full Text] [PDF] |
||||
![]() |
H. G. Rushton `Top down' approach to evaluating children with UTIs shows promise AAP News, June 1, 2006; 27(6): 14 - 15. [Full Text] |
||||
![]() |
Antibiotic Prophylaxis for Vesicoureteral Reflux May Not Be Necessary Journal Watch Pediatrics and Adolescent Medicine, April 21, 2006; 2006(421): 3 - 3. [Full Text] |
||||
![]() |
UTIs, Vesicoureteral Reflux, and Antibiotic Prophylaxis Journal Watch (General), March 28, 2006; 2006(328): 5 - 5. [Full Text] |
||||
![]() |
E. R. Wald Vesicoureteral Reflux: The Role of Antibiotic Prophylaxis Pediatrics, March 1, 2006; 117(3): 919 - 922. [Full Text] [PDF] |
||||
Read all P3Rs